Trials
Search / Trial NCT05652179

SGB Reduces the Incidence and Severity of CSA-AKI

Launched by YANGZHOU UNIVERSITY · Dec 5, 2022

Trial Information

Current as of February 05, 2025

Completed

Keywords

Stellate Ganglion Block Cardiac Surgery Acute Kidney Injury Sympathetic Nerve Renal Artery Resistance Index

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients of any gender were eligible provided they were between the ages of 18 and 80 years;
  • 2. American Society of Anesthesiologists (ASA) class of Ⅲ or IV.
  • Exclusion Criteria:
  • 1. emergency cardiac surgery;
  • 2. major vascular surgery;
  • 3. non-sinus rhythm, reoperation;
  • 4. contraindications for TEE or SGB;
  • 5. abnormal preoperative renal function;
  • 6. severe preoperative heart failure with left ventricular ejection fraction \< 30%, multi-organ dysfunction;
  • 7. and severe infection requiring continuous antibiotic treatment;
  • 8. enrolled in another clinical trial.
  • Elimination criteria:
  • 1. incomplete follow-up data;
  • 2. withdrawal during the procedure;
  • 3. SGB failure or complications;
  • 4. insufficient ultrasonographic imaging of the left renal artery on TEE;
  • 5. repeated CPB during surgery;
  • 6. need for cardiac assist devices (extracorporeal membrane oxygenation, intra-aortic balloon pump, or ventricular assist devices) after CPB completion.

About Yangzhou University

Yangzhou University is a prestigious educational and research institution located in Yangzhou, China, dedicated to advancing knowledge and innovation in various fields, including medicine and healthcare. As a clinical trial sponsor, Yangzhou University leverages its extensive academic resources and expertise to conduct high-quality research aimed at improving patient outcomes and contributing to the scientific community. The university fosters collaboration among multidisciplinary teams and emphasizes ethical practices and regulatory compliance in its clinical research endeavors, ensuring the integrity and reliability of its findings. Through its commitment to excellence, Yangzhou University strives to enhance the understanding of health-related issues and develop effective interventions that benefit society.

Locations

Yangzhou, Jiangsu, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials